Navigation Links
Teva's Forum Draws Key Pennsylvania Healthcare Leaders
Date:7/30/2009

State Influentials Gather to Discuss the Rising Cost of Medicine for Consumers

PHILADELPHIA, July 30 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today hosted the last in a series of roundtable discussions focused on increasing access to healthcare and affordable medicines in the United States.

The event was held as a part of the company's Year of Affordable Healthcare Campaign (www.yearofaffordablehealth.com), which marks the 25th anniversary of the passing of the Hatch-Waxman Act, a bill which created the modern day pharmaceutical drug industry.

The event featured panelists from around the Philadelphia area, all of whom have distinguished themselves by helping to bring affordable healthcare solutions to the people of Pennsylvania. They included:

  • Thomas Snedden, Director, Pennsylvania Pharmaceutical Assistance Contract for the Elderly
  • Pat Halpin-Murphy, President and Founder, Pennsylvania Breast Cancer Coalition
  • Dr. Janet Young, Medical Director, Greater Philadelphia Health Action, Inc.
  • Donna Duncan, Executive Director, Philadelphia's Linda Creed Breast Cancer Foundation

The panel was moderated by Pam Gilbert, partner at Cuneo Gilbert & LaDuca and former executive director of the Consumer Product Safety Commission.

"We are now at a crucial point in this debate," said Debra Barrett, Senior Vice President of Government Affairs for Teva Pharmaceuticals USA. "Healthcare costs continue to rise and consumers in some cases are struggling to access care. We need to ensure that affordable medicine options like biogenerics are available, so that Pennsylvania citizens don't have to worry about being able to afford their prescriptions."

The spirited discussion centered around the need for healthcare reform, the steadily increasing costs of medicines and treatments and potential solutions for these rising costs -- including the development of a pathway for generic biologic medicines.

About Teva USA

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
2. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
3. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
4. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
5. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
6. Sponsor of Presidential Health Care Forum Has a $4 Billion Conflict of Interest: Kucinich
7. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
8. National Quality Forum Announces New Member Councils Leadership
9. American Society of Transplantations Past President Testifies Before Congress at Forum on Organ Donation
10. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
11. SGX Pharmaceuticals to Present at the BIO InvestorForum 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Drs. ... NY, who have now spent 10 years as clinical instructors for the reputable ... College of Dentistry. Through the program, private practitioners receive cutting-edge clinical training and ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Curry Leavitt, a noted ... Periodontal Practice) continuing education (CE) series. As a compassionate and dedicated clinician, Dr. ... attending numerous CE courses each year. His recent course, Course II of HP3, ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... is offering holistic pediatric dentistry options for its patients on Long Island, New ... patient’s entire physical well being, and is one of the biggest trends in ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dymedix® ... diagnostics sensors, announced today it had completed the first phase of building a ... domestic and rest of world (ROW) authorized dealers specializing in polysomnography accessories. ...
(Date:5/23/2017)... ... 23, 2017 , ... Cambridge, MA, May 23, 2017—Total costs ... to a Workers Compensation Research Institute (WCRI) study, a contrast from the increases ... CompScope™ Benchmarks, 17th Edition looks at indemnity and medical payments for workers’ ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed ... a health care service center company based in ... in relationship management programs for leading pharmaceutical manufacturers and ... WRB will join Envoy Health Management, LLC ... manufacturers, biotech firms, and other service companies. Together, WRB ...
(Date:5/4/2017)... , May 4, 2017  A recent ... Control, Ultraviolet-C light as a means ... SmartUVC,s ability to reduce bioburden on anesthesia workstations. ... reduction on high-touch, complex medical equipment surfaces contaminated ... infections. "This study further validates the ...
(Date:5/4/2017)... Wash. , May 4, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media ("BioLife" or the "Company"), today announced that the ... after market close on Thursday, May 11, 2017, and ... live webcast at 1:30 p.m. PT that afternoon. Management ...
Breaking Medicine Technology: